Reliability of CMV-IgG kinetics in the diagnosis of CMV primary infection: sensitivity, specificity, and clinical implications
Microbiology Spectrum · 05.08.2025 · 13 (8)
DOI: 10.1128/spectrum.00455-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.08.2025. Verfasst von Vincent Portet Sulla und 8 weiteren Autor:innen. Beteiligte Einrichtung: WHO Rubella National Reference Laboratory, Division of Virology, Department of Biology Genetics, Paul Brousse Hospital, Paris Saclay University Hospi…. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Immunoglobulin G, Antibodies, Viral, Cytomegalovirus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diagnosis of cytomegalovirus (CMV) primary infection (PI) during pregnancy relies on serology (CMV-IgG, IgM, and IgG avidity). However, as for toxoplasmosis, subsequent serology testing 3–5 weeks later is often performed to confirm the diagnosis. In this study, we aimed to show that testing CMV-IgG with different assays may lead to misinterpretation of CMV-IgG kinetics and to determine the sensitivity and specificity of CMV-IgG stability and significant increase to exclude or confirm recent CMV PI. We conducted a retrospective study on (i) a CMV-IgG external quality control program (2015–2022) and (ii) on CMV serology results obtained in our virology laboratory (2013–2023) in pregnant women with positive CMV-IgM and a subsequent serum sample collected 3–5 weeks later. Analysis of 21 CMV-IgG external quality control serum samples highlighted significant differences in CMV-IgG values, with variations up to a factor of 185 between different immunoassays for the same positive sample. In 434 pregnant women, the sensitivity of a significant CMV-IgG increase to predict recent PI was 32.9% (95% CI = 26.5–39.2), while CMV-IgG stability specificity to exclude PI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO Rubella National Reference Laboratory, Division of Virology, Department of Biology Genetics, Paul Brousse Hospital, Paris Saclay University Hospital, APHP, Villejuif, France.
- Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Paris Saclay University, INSERM U1184, CEA, Fontenay-aux-Roses, France.
- Biologie Prospective, Villers les Nancy, France.
- Department of Virology, Angers University Hospital, Angers, France.
- Virology Department, Sorbonne University, Saint-Antoine Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Paris, France.
ORCID-Profile: Vincent Portet Sulla
Zitieren
APA
Portet Sulla, V., Rafek, R., Bertin-Jung, I., Siest, J. P., Bouthry, E., Rogier, O., Jadoui, A., Vauloup-Fellous, C., & Perillaud-Dubois, C. (2025). Reliability of CMV-IgG kinetics in the diagnosis of CMV primary infection: sensitivity, specificity, and clinical implications. Microbiology Spectrum, 13(8). https://doi.org/10.1128/spectrum.00455-25
Vancouver
Portet Sulla V, Rafek R, Bertin-Jung I, Siest JP, Bouthry E, Rogier O, et al. Reliability of CMV-IgG kinetics in the diagnosis of CMV primary infection: sensitivity, specificity, and clinical implications. Microbiology Spectrum. 2025;13(8). doi:10.1128/spectrum.00455-25
BibTeX
@article{PortetSulla2025,
author = {Portet Sulla, Vincent and Rafek, Rana and Bertin-Jung, Isabelle and Siest, Jean-Pascal and Bouthry, Elise and Rogier, Olivier and Jadoui, Abir and Vauloup-Fellous, Christelle and Perillaud-Dubois, Claire},
title = {Reliability of CMV-IgG kinetics in the diagnosis of CMV primary infection: sensitivity, specificity, and clinical implications},
journal = {Microbiology Spectrum},
year = {2025},
volume = {13},
number = {8},
doi = {10.1128/spectrum.00455-25}
}
EUVIMED